Medtronic Saw Strong 2Q Results; No Change to Our FVE
Despite foreign exchange headwinds, Medtronic posted another quarter of strong, above-market growth that generally met our expectations, and we’re holding steady on our fair value. Medtronic saw strength across many of its product categories thanks to increasing adoption of new products. The firm’s ability to consistently roll out new technologies underscores our view that Medtronic enjoys a wide economic moat. Moreover, regulatory and reimbursement hurdles have risen higher as value-based reimb...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.